Mulberry Biotherapeutics

Private

Wellesley, MassachusettsHealthcare & Life Scienceshttps://www.mulberrybio.com/

Last Round

M&A

Oct 1, 2025

Company Overview

Mulberry Biotherapeutics is a biotechnology company developing bacteria-mediated immunotherapies for the treatment of rare, slow-growing tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

bacteria-mediated immunotherapytumor microenvironmentclinical-stage biotechintratumoral injectionrare disease therapysynthetic biologyoncolytic bacterianeurofibromatosisschwannomatosislive biotherapeuticdrug developmentbio-pharmameningioma treatmenthypoxic tumorbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mulberry Biotherapeutics Comps

Public and private peers based on sector, stage, and business model.

Mulberry Biotherapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mulberry Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	Oct 1, 2025
VC Round	Apr 20, 2021

View all Funding Rounds

Mulberry Biotherapeutics Investors

Notable investors and investment history

Mulberry Biotherapeutics investors
Investor	Rounds
Community Impact Ventures	VC Round

View all Investors

Mulberry Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Mulberry Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mulberry Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWellesley, Massachusetts

Employee Range3

Year Founded2021

Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.